ADRB2 Genotyping for Beta-2 Agonist Responsiveness Test
Test Cost: AED 960.0
Symptoms Diagnosis: No Special preparation required
Test Name: ADRB2 Genotyping for Beta-2 Agonist Responsiveness
Test Components: PCR Sequencing
Price: 960.0 AED
Sample Condition: 4 mL (2 mL min.) whole Blood in 1 Lavender top (EDTA) Tube. Ship refrigerated. DO NOT FREEZE.
Report Delivery: SampleSat by 11 am; Report 10 Working days
Method: PCR Sequencing
Test Type: Pharmacogenomics
Doctor: Physician
Test Department: Molecular Diagnostics
Pre Test Information: No Special preparation required
What is ADRB2 Genotyping for Beta-2 Agonist Responsiveness?
ADRB2 genotyping for beta-2 agonist responsiveness is a genetic test that examines variations in the ADRB2 gene, which codes for the beta-2 adrenergic receptor. This receptor is the target for beta-2 agonist medications, such as albuterol, which are commonly used to treat asthma and other respiratory conditions.
The purpose of this test is to identify specific variations in the ADRB2 gene that may impact an individual’s response to beta-2 agonist medications. Some genetic variations in this gene have been associated with increased or decreased responsiveness to these medications.
By identifying these genetic variations, healthcare providers can personalize treatment plans for individuals with respiratory conditions. This can help optimize medication selection and dosing, leading to better symptom control and improved overall health outcomes.
How is the Test Performed?
The test is typically performed using a sample of DNA, which can be obtained from a blood sample or a cheek swab. The DNA is then analyzed to identify any variations in the ADRB2 gene.
It is important to note that while this test can provide valuable information, it is just one factor to consider when determining the most appropriate treatment plan. Other factors, such as an individual’s medical history, symptoms, and other genetic variations, should also be taken into account.
Conclusion
ADRB2 genotyping for beta-2 agonist responsiveness is a useful tool for personalized medicine in the treatment of respiratory conditions. It can help healthcare providers make more informed decisions about medication selection and dosing, leading to improved outcomes for individuals with these conditions.
| Test Name | ADRB2 GENOTYPING FOR BETA-2 AGONIST RESPONSIVENESS Test |
|---|---|
| Components | |
| Price | 960.0 AED |
| Sample Condition | 4 mL (2 mL min.) whole Blood in 1 Lavender top (EDTA) Tube. Ship refrigerated. DO NOT FREEZE. |
| Report Delivery | SampleSat by 11 am;Report 10 Working days |
| Method | PCR Sequencing |
| Test type | Pharmacogenomics |
| Doctor | Physician |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | No Special preparation required |
| Test Details | ADRB2 genotyping for beta-2 agonist responsiveness is a genetic test that examines variations in the ADRB2 gene, which codes for the beta-2 adrenergic receptor. This receptor is the target for beta-2 agonist medications, such as albuterol, which are commonly used to treat asthma and other respiratory conditions. The purpose of this test is to identify specific variations in the ADRB2 gene that may impact an individual’s response to beta-2 agonist medications. Some genetic variations in this gene have been associated with increased or decreased responsiveness to these medications. By identifying these genetic variations, healthcare providers can personalize treatment plans for individuals with respiratory conditions. This can help optimize medication selection and dosing, leading to better symptom control and improved overall health outcomes. The test is typically performed using a sample of DNA, which can be obtained from a blood sample or a cheek swab. The DNA is then analyzed to identify any variations in the ADRB2 gene. It is important to note that while this test can provide valuable information, it is just one factor to consider when determining the most appropriate treatment plan. Other factors, such as an individual’s medical history, symptoms, and other genetic variations, should also be taken into account. Overall, ADRB2 genotyping for beta-2 agonist responsiveness is a useful tool for personalized medicine in the treatment of respiratory conditions. It can help healthcare providers make more informed decisions about medication selection and dosing, leading to improved outcomes for individuals with these conditions. |
